22157.jpg
Global Uveitis Treatment Research Report 2024: Market to Reach $1.34 Billion by 2034, Fueled by Increased Prevalence, Treatment Improvements, and Strategic Alliances & Collaborations
16 mai 2024 10h30 HE | Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Global Uveitis Treatment Market" report has been added to ResearchAndMarkets.com's offering.The global uveitis treatment market accounted for USD 753...
AFB Releases Phase 2 Study of Barriers to Digital Inclusion
10 mai 2024 12h39 HE | American Foundation for the Blind
AFB Researchers uncover further barriers to digital inclusion for blind and low vision.
Global Macular Degeneration Treatment Market
Global $15.4 Billion Macular Degeneration Treatment Market, 2032: Modern Dietary Routines and Sedentary Lifestyles Driving the Incidence of Macular Degeneration
07 mai 2024 12h39 HE | Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Global Macular Degeneration Treatment Market Report by Type, Stage of Disease, Route of Administration, End User, and Region 2024-2032" report has been...
22157.jpg
Ophthalmic Devices Sector: Comprehensive Analysis Reveals Accelerated Growth in Corneal Implants Market Through 2033
01 févr. 2024 11h05 HE | Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Corneal Implants Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...
DEI Logo (1).png
Doheny Eye Institute Research Breakthrough: An Inherited Mutation Blinds Young Adult Males By Disturbing Mitochondrial Quantum Electron Tunneling
29 janv. 2024 12h05 HE | Doheny Eye Institute
PASADENA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, is pleased to announce the publication of important new findings...
Global Diabetic Retinopathy Market
Global Diabetic Retinopathy Market Size, Share & Trends Analysis Report 2024-2030: Non-Proliferative Diabetic Retinopathy Accounted for the Largest Share, By Type in 2023
24 janv. 2024 05h35 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetic Retinopathy Market Size, Share & Trends Analysis Report by Type (Proliferative DR, Non-Proliferative DR), Management (Anti-VEGF...
logo_h.jpg
Alkeus Pharmaceuticals Presents Positive Gildeuretinol Trial Results at American Academy of Ophthalmology, Demonstrating Significant Slowing of Retinal Atrophic Lesions in Stargardt Disease
03 nov. 2023 12h00 HE | Alkeus Pharmaceuticals
Primary endpoint met, demonstrating a 21% slowing (p<0.001) in the growth rate of atrophic retinal lesions compared to the untreated arm; 28% reduction (p<0.001) using observed atrophic...
Global Retinal Implants Market
Global Retinal Implant Market Anticipates Rapid Growth, Expected to Reach $112.2 Million by 2030
30 oct. 2023 11h18 HE | Research and Markets
Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The "Retinal Implants Market Size, Share & Trends Analysis Report By Device Type (Retina Implant Alpha AMS, Implantable Miniature Telescope, Argus II),...
OE_60th_logoRGB.jpg
Join Operation Eyesight for an inspiring night at the movies at the Infinity Dome theatre on Oct. 26
20 oct. 2023 07h00 HE | Operation Eyesight
Calgarians are invited to join Operation Eyesight for an inspiring night at the movies at TELUS Spark’s Infinity Dome theatre on October 26.
RetinalGeniX Logo Revised Sept 2023.jpg
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
18 sept. 2023 05h59 HE | RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding...